SCHEMBL20122395

SCHEMBL20122395

CC(C)(SC(=O)OCOC(=O)c1ccccc1)C(=O)N[C@@H](CSC(=O)OCOC(=O)c1ccccc1)C(=O)OC1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ SCN1A P35498 1/20 0.37
▸ SCN2A Q99250 1/20 0.37
▸ SCN3A Q9NY46 1/20 0.37
▸ ADRB2 P07550 2/20 0.35
▸ ADRB1 P08588 2/20 0.35
▸ ADRB3 P13945 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ MMP2 P08253 2/20 0.33
▸ MMP9 P14780 2/20 0.33
▸ ANPEP P15144 2/20 0.33
▸ LTA4H P09960 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122367 0.90 SMN1; SMN2 (0.38) LMNASMN1; SMN2RAB9ACYP1A2CYP2D6
SCHEMBL20122516 0.87 ADRB2 (0.41) LMNACYP2D6SCN1ASCN2ASCN3A
SCHEMBL20122555 0.86 ADRB2 (0.40) LMNACYP2D6SCN1ASCN2ASCN3A
SCHEMBL20122398 0.85 EPHX1 (0.30) —
SCHEMBL20122445 0.85 ADRB2 (0.41) LMNACYP2D6SCN1ASCN2ASCN3A
SCHEMBL20122556 0.84 ADRB2 (0.39) LMNASMN1; SMN2RAB9ACYP2D6NPC1
SCHEMBL20122388 0.84 ADRB2 (0.39) CYP2D6SCN1ASCN2ASCN3AADRB2
SCHEMBL20122506 0.84 CYP19A1 (0.30) —
SCHEMBL20122580 0.84 NPC1 (0.31) SMN1; SMN2RAB9ANPC1HTT
SCHEMBL20122380 0.84 EPHX1 (0.32) CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback